Financhill
Back

FibroGen 10K Form

Sell
41

FGEN
FibroGen

Last Price:
0.31
Seasonality Move:
45.73%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive FGEN News And Ratings

See the #1 stock for the next 7 days that we like better than FGEN

FGEN Financial Statistics

Sales & Book Value

Annual Sales: $147.75M
Cash Flow: $-39.88M
Price / Cash Flow: 0
Annual Sales: $-2.31
Price / Book: 0

Profitability

EPS (TTM): -1.71000
Net Income (TTM): $-168.32M
Gross Margin: $128.9M
Return on Equity: 0%
Return on Assets: -40.89%

FibroGen Earnings Forecast

Key FibroGen Financial Ratios

  • The Gross Profit Margin over the past 11 years for FGEN is 87.24%.
  • The Selling, General & Administrative Expenses for FGEN have been equal to 78.00% of Gross Profit Margin.
  • The Research & Development expenses have been 191.44% of Revenue.
  • The Interest Expense is -5.46% of Operating Income.
  • The Net Earning history of FGEN is -192.37% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 6 years.

FibroGen Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: FGEN
CUSIP: 31572Q
Website: fibrogen.com

Debt

Debt-to-Equity Ratio: -0.31
Current Ratio: 1.41
Quick Ratio: 1.18

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

FGEN Technical Analysis vs Fundamental Analysis

Sell
41
FibroGen (FGEN) is a Sell

Is FibroGen a Buy or a Sell?

  • FibroGen stock is rated a Sell
    The current FibroGen [FGEN] share price is $0.32. The Score for FGEN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.